Skip to main content
Web Page

Recombinant Humanized Anti-HER2 Antibody (Herceptin™) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts1 | Cancer Research | American Association for Cancer Research

N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Recombinant Humanized Anti-HER2 Antibody (HerceptinTM) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts1 | Cancer Research | American Association for Cancer Research. (n.d.). Retrieved from https://aacrjournals.org/cancerres/article/58/13/2825/504207/Recombinant-Humanized-Anti-HER2-Antibody

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Save time finding and organizing research with Mendeley

Sign up for free